MetaStat, Inc. Stock Other OTC
Equities
MTST
US59140A2033
Biotechnology & Medical Research
Sales 2017 | - | Sales 2018 | 0.02 0.03 | Capitalization | 6.98M 9.56M |
---|---|---|---|---|---|
Net income 2017 | -2M -2.74M | Net income 2018 | -3M -4.11M | EV / Sales 2017 | - |
Net Debt 2017 | 206K 282K | Net Debt 2018 | 683K 935K | EV / Sales 2018 | 329,023,519 x |
P/E ratio 2017 |
-0.72
x | P/E ratio 2018 |
-2.02
x | Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 98.43% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 14-07-31 | |
Frederick Pierce
IRC | Investor Relations Contact | 63 | 15-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 14-07-31 | |
Paul Billings
BRD | Director/Board Member | 71 | 17-05-23 |
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |